Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 1996; Volume 24,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Allen, E M

    1. You have access
      Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;
  2. Angelin, B

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  3. Arvidsson, T

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  4. Askemark, Y

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

B

  1. Bend, J R

    1. You have access
      Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
      C J Sinal and J R Bend
      Drug Metabolism and Disposition September 1996, 24 (9) 996-1001;
  2. Bort, R

    1. You have access
      Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;
  3. Bredberg, E

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  4. Burke, M D

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;
  5. Bush, E

    1. You have access
      Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

C

  1. Carrasco, E

    1. You have access
      Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;
  2. Castell, J V

    1. You have access
      Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;
  3. Czerwinski, M

    1. You have access
      Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;

D

  1. Darbyshire, J F

    1. You have access
      Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;
  2. Davis, C B

    1. You have access
      Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;
  3. Dean, J M

    1. You have access
      Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

E

  1. Ekins, S

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;
  2. Ekström, G

    1. You have access
      Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
      G Ekström and U B Gunnarsson
      Drug Metabolism and Disposition September 1996, 24 (9) 955-961;
  3. Elofsson, S

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  4. Engeset, J

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;
  5. Evans, A M

    1. You have access
      Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

F

  1. Fairchild, B A

    1. You have access
      Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;
  2. Feierman, D E

    1. You have access
      Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
      D E Feierman and J M Lasker
      Drug Metabolism and Disposition September 1996, 24 (9) 932-939;

G

  1. Garver, E M

    1. You have access
      Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;
  2. Ghosal, A

    1. You have access
      Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;
  3. Gibbs, J P

    1. You have access
      Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;
  4. Gómez-Lechón, M J

    1. You have access
      Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;
  5. Grogan, J

    1. You have access
      Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;
  6. Guenthner, T M

    1. You have access
      Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1996, 24 (9) 1020-1027;
  7. Gunnarsson, U B

    1. You have access
      Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
      G Ekström and U B Gunnarsson
      Drug Metabolism and Disposition September 1996, 24 (9) 955-961;

H

  1. Halldin, M M

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  2. Hawksworth, G M

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;
  3. Heyn, H

    1. You have access
      Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;

I

  1. Iyer, K R

    1. You have access
      Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

K

  1. Kapetanovic, I M

    1. You have access
      Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;
  2. Kattnig, M J

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  3. Kharasch, E D

    1. You have access
      Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;
  4. Korzekwa, K R

    1. You have access
      Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;
  5. Kupferberg, H J

    1. You have access
      Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;
  6. Kwok, D C

    1. You have access
      Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

L

  1. Larsen-Su, S

    1. You have access
      Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.
      S Larsen-Su and D E Williams
      Drug Metabolism and Disposition September 1996, 24 (9) 927-931;
  2. Lasker, J M

    1. You have access
      Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
      D E Feierman and J M Lasker
      Drug Metabolism and Disposition September 1996, 24 (9) 932-939;
  3. Liebler, D C

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  4. Luo, G

    1. You have access
      Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1996, 24 (9) 1020-1027;

M

  1. Marchant, N C

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;
  2. Mayersohn, M

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  3. McNeilly, P J

    1. You have access
      Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;
  4. Moore, D

    1. You have access
      Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;
  5. Murray, G I

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

N

  1. Nation, R L

    1. You have access
      Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

P

  1. Pappas, J B

    1. You have access
      Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;
  2. Pillai, U A

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  3. Ponsoda, X

    1. You have access
      Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

R

  1. Rowin, M

    1. You have access
      Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

S

  1. Sallustio, B C

    1. You have access
      Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;
  2. Satoh, H

    1. You have access
      Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;
  3. Shanahan, K

    1. You have access
      Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;
  4. Sinal, C J

    1. You have access
      Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
      C J Sinal and J R Bend
      Drug Metabolism and Disposition September 1996, 24 (9) 996-1001;
  5. Sipes, I G

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  6. Slattery, J T

    1. You have access
      Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;
  7. Smith, R L

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
  8. Spracklin, D K

    1. You have access
      Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;
  9. Stevens, J C

    1. You have access
      Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;
  10. Strong, J M

    1. You have access
      Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

T

  1. Thomas, P E

    1. You have access
      Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;
  2. Thummel, K E

    1. You have access
      Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;
  3. Torchin, C D

    1. You have access
      Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;
  4. Trager, W F

    1. You have access
      Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

U

  1. Urbanski, J J

    1. You have access
      Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

V

  1. Vernon, D D

    1. You have access
      Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

W

  1. White, R B

    1. You have access
      Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;
  2. Widman, M

    1. You have access
      Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;
  3. Williams, D E

    1. You have access
      Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.
      S Larsen-Su and D E Williams
      Drug Metabolism and Disposition September 1996, 24 (9) 927-931;
  4. Williams, J A

    1. You have access
      Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

Z

  1. Ziegler, T L

    1. You have access
      Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 24, Issue 9
1 Sep 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Metabolism and Disposition of Volanesorsen across Species
  • Transporter-Mediated Drug-Drug Interactions for E7766
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics